At the end of the day, the share price can dip and rise like the others (has only been steadily rising which is a better sign

) - however the company sentiment and plans aren't changing. Waiting now on a really nice Ann to clarify what we will be tackling in the coming future and possible sale prices for their harvest in Chile and an update on importing cannabis from Canopy.
Hopefully an update on these pointers from last ann:
23 FEBRUARY 2017
• AusCann welcomes Federal Government’s move to facilitate faster access to medical cannabis for patients
• Government to expedite the authorisation process for the controlled importation by approved providers to enable patients to more rapidly access the medication
16 FEBRUARY 2017
• AusCann intends to import high quality cannabis medicines from its partner Canopy Corporation, one of the world’s largest medicinal cannabis companies, and following this announcement, its process for importing has become more streamlined.
• The news propels AusCann’s strategy to deliver high quality, cost effective medicinal cannabis treatments to Australian patients. Eight different strains are being grown providing a range of chemical entities/ chemotypes to be used in trial formulations
• Product intended to be sold to third parties for use in a range of clinical trials later this year
• Successful trials will result in product registration driving demand and subsequent commercial sales.
A good announcement on most of these pointers that they have been working on will begin to turn heads. The key pointer I'm expecting to see would be anything to do with revenue. I want to see us making coin off our back.